Literature DB >> 28062502

Targeting Elastase for Molecular Imaging of Early Atherosclerotic Lesions.

Almut Glinzer1, Xiaopeng Ma1, Jaya Prakash1, Melanie A Kimm1, Fabian Lohöfer1, Katja Kosanke1, Jaroslav Pelisek1, Moritz P Thon1, Sandra Vorlova1, Katrin G Heinze1, Hans-Henning Eckstein1, Michael W Gee1, Vasilis Ntziachristos1, Alma Zernecke1, Moritz Wildgruber2.   

Abstract

OBJECTIVE: Neutrophils accumulate in early atherosclerotic lesions and promote lesion growth. In this study, we evaluated an elastase-specific near-infrared imaging agent for molecular imaging using hybrid fluorescence molecular tomography/x-ray computed tomography. APPROACH AND
RESULTS: Murine neutrophils were isolated from bone marrow and incubated with the neutrophil-targeted near-infrared imaging agent Neutrophil Elastase 680 FAST for proof of principle experiments, verifying that the elastase-targeted fluorescent agent is specifically cleaved and activated by neutrophil content after lysis or cell stimulation. For in vivo experiments, low-density lipoprotein receptor-deficient mice were placed on a Western-type diet and imaged after 4, 8, and 12 weeks by fluorescence molecular tomography/x-ray computed tomography. Although this agent remains silent on injection, it produces fluorescent signal after cleavage by neutrophil elastase. After hybrid fluorescence molecular tomography/x-ray computed tomography imaging, mice were euthanized for whole-body cryosectioning and histological analyses. The in vivo fluorescent signal in the area of the aortic arch was highest after 4 weeks of high-fat diet feeding and decreased at 8 and 12 weeks. Ex vivo whole-body cryoslicing confirmed the fluorescent signal to locate to the aortic arch and to originate from the atherosclerotic arterial wall. Histological analysis demonstrated the presence of neutrophils in atherosclerotic lesions.
CONCLUSIONS: This study provides evidence that elastase-targeted imaging can be used for in vivo detection of early atherosclerosis. This imaging approach may harbor potential in the clinical setting for earlier diagnosis and treatment of atherosclerosis.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  arteriosclerosis; cardiovascular disease; fluorescence molecular tomography; imaging; neutrophils

Mesh:

Substances:

Year:  2016        PMID: 28062502     DOI: 10.1161/ATVBAHA.116.308726

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Protease Activity in Vascular Disease.

Authors:  Megan A Slack; Scott M Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-25       Impact factor: 8.311

2.  Paradigms in Fluorescence Molecular Imaging: Maximizing Measurement of Biological Changes in Disease, Therapeutic Efficacy, and Toxicology/Safety.

Authors:  Jeffrey D Peterson
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

3.  Short-wavelength optoacoustic spectroscopy based on water muting.

Authors:  Jaya Prakash; Mir Mehdi Seyedebrahimi; Ara Ghazaryan; Jaber Malekzadeh-Najafabadi; Vipul Gujrati; Vasilis Ntziachristos
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-06       Impact factor: 11.205

4.  Updates on Approaches for Studying Atherosclerosis.

Authors:  Congqing Wu; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

5.  Survey of Approaches for Investigation of Atherosclerosis In Vivo.

Authors:  Dipak P Ramji; Yee-Hung Chan; Alaa Alahmadi; Reem Alotibi; Nouf Alshehri
Journal:  Methods Mol Biol       Date:  2022

6.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 7.  Current and Emerging Preclinical Approaches for Imaging-Based Characterization of Atherosclerosis.

Authors:  Jonathan Vigne; James Thackeray; Jeroen Essers; Marcus Makowski; Zoreh Varasteh; Adelina Curaj; Angelos Karlas; Emmanuel Canet-Soulas; Willem Mulder; Fabian Kiessling; Michael Schäfers; René Botnar; Moritz Wildgruber; Fabien Hyafil
Journal:  Mol Imaging Biol       Date:  2018-12       Impact factor: 3.488

8.  Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis.

Authors:  Guanmei Wen; Weiwei An; Jiangyong Chen; Eithne M Maguire; Qishan Chen; Feng Yang; Stuart W A Pearce; Maria Kyriakides; Li Zhang; Shu Ye; Sussan Nourshargh; Qingzhong Xiao
Journal:  J Am Heart Assoc       Date:  2018-02-08       Impact factor: 5.501

9.  Bioengineered bacterial vesicles as biological nano-heaters for optoacoustic imaging.

Authors:  Vipul Gujrati; Jaya Prakash; Jaber Malekzadeh-Najafabadi; Andre Stiel; Uwe Klemm; Gabriele Mettenleiter; Michaela Aichler; Axel Walch; Vasilis Ntziachristos
Journal:  Nat Commun       Date:  2019-03-07       Impact factor: 14.919

10.  Preclinical techniques to investigate exercise training in vascular pathophysiology.

Authors:  Gurneet S Sangha; Craig J Goergen; Steven J Prior; Sushant M Ranadive; Alisa M Clyne
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-01       Impact factor: 5.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.